COMPARATIVE ANALYSIS OF INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA, PROGRESSION-RISK SCORE AND MD ANDERSON CANCER CENTER 2011 SCORE: REAL WORLD DATA FROM A SINGLE INSTITUTION

被引：0
|
作者：
Vukovic, V. [1 ]
Antic, D. [1 ,2 ]
Karan-Djurasevic, T. [3 ]
Milic, N. [4 ]
Todorovic-Balint, M. [1 ,2 ]
Bila, J. [1 ,2 ]
Andjelic, B. [1 ,2 ]
Djurasinovic, V. [1 ,2 ]
Sretenovic, A. [1 ]
Smiljanic, M. [1 ]
Jelicic, J. [1 ]
Dencic-Fekete, M. [1 ]
Perunicic-Jovanovic, M. [1 ]
Kraguljac-Kurtovic, N. [1 ]
Pavlovic, S. [3 ]
Mihaljevic, B. [1 ,2 ]
机构：
[1] Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia
[2] Univ Belgrade, Fac Med, Belgrade, Serbia
[3] Inst Mol Genet & Genet Engn, Lab Mol Biomed, Belgrade, Serbia
[4] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1793
引用
收藏
页码：719 / 719
页数：1
相关论文
共 15 条
  • [1] Comparative analysis of International Prognostic Index for Chronic Lymphocytic Leukemia, progression-risk score, and MD Anderson Cancer Center 2011 score - a single center experience
    Mihaljevic, Biljana
    Vukovic, Vojin
    Milic, Natasa
    Karan-Djurasevic, Teodora
    Tosic, Natasa
    Kostic, Tatjana
    Marjanovic, Irena
    Dencic-Fekete, Marija
    Djurasinovic, Vladislava
    Dragovic-Ivancevic, Tijana
    Pavlovic, Sonja
    Antic, Darko
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2021, 149 (7-8) : 415 - 421
  • [2] VALIDATION OF THE NEW INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL-IPI) AND MODIFIED SCORE USED IN THE MD ANDERSON CANCER CENTER (MDACC)
    Isabel, Gonzalez-Gascon y Marin
    Maria, Poza
    Sanchez Maria, Hernandez
    Ana Eugenia, Rodriguez Vicente
    Maria, Infante
    Maria Angeles, Foncillas
    Karen, Marin
    Novas Carolina, Munoz
    Cecilia, Heras
    Jesus Maria, Hernandez Rivas
    Jose Angel, Hernandez
    HAEMATOLOGICA, 2016, 101 : 338 - 338
  • [3] CHRONIC LYMPHOCYTIC LEUKEMIA MD ANDERSON CANCER CENTER PROGNOSTIC INDEX IS SUCCESSFUL BUT STILL CAN BE IMPROVED BY INCORPORATING SERUM LDH LEVEL
    Gunes, G.
    Buyukasik, Y.
    Aslan, N. Alayvaz
    Malkan, U. Y.
    Haznedaroglu, I. C.
    Demiroglu, H.
    Goker, H.
    Etgul, S.
    Aslan, T.
    Balaban, S.
    Ozcebe, O. I.
    Aksu, S.
    Karakus, S.
    Sayinalp, N.
    HAEMATOLOGICA, 2015, 100 : 54 - 55
  • [4] Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
    Kim, Haesook T.
    Ahn, Kwang Woo
    Hu, Zhen-Huan
    Davids, Matthew S.
    Volpe, Virginia O.
    Antin, Joseph H.
    Sorror, Mohamed L.
    Shadman, Mazyar
    Press, Oliver
    Pidala, Joseph
    Hogan, William
    Negrin, Robert
    Devine, Steven
    Uberti, Joseph
    Agura, Edward
    Nash, Richard
    Mehta, Jayesh
    McGuirk, Joseph
    Forman, Stephen
    Langston, Amelia
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Battiwalla, Minoo
    Hale, Gregory A.
    Gale, Robert Peter
    Marks, David I.
    Hamadani, Mehdi
    Ganguly, Sid
    Bacher, Ulrike
    Lazarus, Hillard
    Reshef, Ran
    Hildebrandt, Gerhard C.
    Inamoto, Yoshihiro
    Cahn, Jean-Yves
    Solh, Melhem
    Kharfan-Dabaja, Mohamed A.
    Ghosh, Nilanjan
    Saad, Ayman
    Aljurf, Mahmoud
    Schouten, Harry C.
    Hill, Brian T.
    Pawarode, Attaphol
    Kindwall-Keller, Tamila
    Saba, Nakhle
    Copelan, Edward A.
    Nathan, Sunita
    Beitinjaneh, Amer
    Savani, Bipin N.
    Cerny, Jan
    Grunwald, Michael R.
    CLINICAL CANCER RESEARCH, 2019, 25 (16) : 5143 - 5155
  • [5] The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
    Munoz-Novas, Carolina
    Poza-Santaella, Maria
    Gonzalez-Gascon y Marin, Isabel
    Hernandez-Sanchez, Maria
    Rodriguez-Vicente, Ana-Eugenia
    Infante, Maria-Stefania
    Heras, Cecilia
    Foncillas, Maria-Angeles
    Marin, Karen
    Hernandez-Rivas, Jesus-Maria
    Hernandez, Jose-Angel
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [6] Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
    Gentile, Massimo
    Mauro, Francesca R.
    Rossi, Davide
    Vincelli, Iolanda
    Tripepi, Giovanni
    Recchia, Anna G.
    De Stefano, Laura
    Campanelli, Melissa
    Giannarelli, Diana
    Bossio, Sabrina
    Morabito, Lucio
    Vigna, Ernesto
    Gaidano, Gianluca
    Foa, Robin
    Morabito, Fortunato
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (02) : 224 - 232
  • [7] Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model
    Molica, Stefano
    Giannarelli, Diana
    Mirabelli, Rosanna
    Levato, Luciano
    Russo, Antonio
    Linardi, Maria
    Gentile, Massimo
    Morabito, Fortunato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 72 - 77
  • [8] A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)
    Stefano Molica
    Diana Giannarelli
    Luciano Levato
    Rosanna Mirabelli
    Massimo Gentile
    Mirella Lentini
    Fortunato Morabito
    International Journal of Hematology, 2014, 100 : 290 - 295
  • [9] A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)
    Molica, Stefano
    Giannarelli, Diana
    Levato, Luciano
    Mirabelli, Rosanna
    Gentile, Massimo
    Lentini, Mirella
    Morabito, Fortunato
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (03) : 290 - 295
  • [10] Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) and Validation of a Proposed Novel Risk Model (BALL Score) in Real-World Relapsed/Refractory (R/R) CLL Patients Receiving Idelalisib and Rituximab
    Gentile, Massimo
    Reda, Gianluigi
    Mauro, Francesca Romana
    Sportoletti, Paolo
    Laurenti, Luca
    Coscia, Marta
    Recchia, Anna G.
    Varettoni, Marzia
    Murru, Roberta
    Chiarenza, Annalisa
    Condoluci, Adalgisa
    Moia, Riccardo
    Pietrasanta, Daniela
    Loseto, Giacomo
    Consoli, Ugo
    Scortechini, Ilaria
    Vigna, Ernesto
    Botta, Cirino
    Fraticelli, Vincenzo Ludovico
    Di Prima, Alessio
    Tripepi, Giovanni
    Rossi, Davide
    Gaidano, Gianluca
    Gattei, Valter
    Morabito, Fortunato
    BLOOD, 2019, 134
12